Role of CXCR3 in fibrotic tissue responses

Alan Wells1,2
1Departments of Pathology, Bioengineering, and Computational & Systems Biology, and McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA
2R&D Service, Pittsburgh VA Health System, Pittsburgh, PA 15213, USA

Tài liệu tham khảo

Aidoudi, 2010, Interaction of PF4 (CXCL4) with the vasculature: a role in atherosclerosis and angiogenesis, Thromb. Haemost., 104, 941 Allen, 2002, EGF-induced matrix contraction is modulated by calpain, Wound Repair Regen., 10, 67, 10.1046/j.1524-475X.2002.10701.x Amatschek, 2011, CXCL9 induces chemotaxis, chemorepulsion and endothelial barrier disruption through CXCR3-mediated activation of melanoma cells, Br. J. Cancer, 104, 469, 10.1038/sj.bjc.6606056 Balesterieri, 2008, Understanding the immunoangiostatic CXC chemokine network, Cardiovasc. Res., 78, 250, 10.1093/cvr/cvn029 Bodnar, 2009, ELR-negative chemokine IP-10/CXCL10 induces dissociation of newly-formed vessels secondary to calpain cleavage of beta3 integrin, J. Cell Sci., 122, 2064, 10.1242/jcs.048793 Bodnar, 2013, Pericyte regulation of vascular remodeling through the CXC Receptor 3, Arterioscler. Thromb. Vasc. Biol., 33, 2818, 10.1161/ATVBAHA.113.302012 Bodnar, 2016, Pericytes: a newly recognized player in wound healing, Wound Repair Regen., 24, 201, 10.1111/wrr.12415 Bodnar, 2015, Differential regulation of pericyte function by the CXC receptor 3, Wound Repair Regen., 22, 785, 10.1111/wrr.12346 Burdick, 2005, CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodeling, Am. J. Respir. Crit. Care Med., 171, 261, 10.1164/rccm.200409-1164OC Chaturvedi, 2015, CXCR3 blockade protects against Listeria monocytogenes infection-induced fetal wastage, J. Clin. Investig., 125, 1713, 10.1172/JCI78578 Flier, 2001, Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation, J. Pathol., 194, 398, 10.1002/1096-9896(200108)194:4<397::AID-PATH899>3.0.CO;2-S Fujimura, 2012, Angiostatic effecto fo CXCR3 expressed on choroidal neovascularization, Investig. Ophthalmol. Visual Sci., 53, 1999, 10.1167/iovs.11-8232 Groover, 2020, Potential therapeutic manipulations of the CXCR3 chemokine axis for the treatment of inflammatory fibrosing diseases, F1000Research, 9, 10.12688/f1000research.26728.1 Huen, 2016, CXCL11 expression by keratinocytes occurs transiently between reaching confluence and cellular compaction, Adv. Wound Care, 5, 517, 10.1089/wound.2015.0680 Huen, 2012, The beginning of the end: CXCR3 signaling in late-stage wound healing, Adv. Wound Care, 1, 244, 10.1089/wound.2011.0355 Ichikawa, 2013, CXCL10-CXCR3 enhances the development of neutrophil-mediated fulminant lung injury of viral and nonviral origin, Am. J. Respir. Crit. Care Med., 187, 65, 10.1164/rccm.201203-0508OC Iwabu, 2004, EGF induces fibroblast contractility and motility via a PKCTM-dependent pathway, J. Biol. Chem., 279, 14551, 10.1074/jbc.M311981200 Jandl, 2022, Impairment of the NKT-STAT1-CXCL9-axis contributes to vessel fibrosis in pulmonary hypertension due to lung fibrosis, Am. J. Respir. Crit. Care Med., 10.1164/rccm.202201-0142OC Jiang, 2010, Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4, J. Clin. Investig., 120, 2049, 10.1172/JCI38644 Keane, 1999, IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis, J. Immunol., 163, 5686, 10.4049/jimmunol.163.10.5686 Korbecki, 2021, The effect of hypoxia on the expression of CXC chemokines and CXC chemokine receptors – a review of the literature, Int. J. Mol. Sci., 22, 10.3390/ijms22020843 Li, 2021, Chemokines in cardiac fibrosis, Curr. Opin. Physiol., 19, 80, 10.1016/j.cophys.2020.10.004 Li, 2020, Mesenchymal stem cells prevent overwhelming inflammation and reduce infection severity via recruiting CXCR3+ regulatory T cells, Clin. Transl. Immunol., 9, 10.1002/cti2.1181 Li, 2015, Divergent roles of CXCR3 isoforms in promoting cancer stem-like cell survival and metastasis, Breast Cancer Res. Treat., 149, 403, 10.1007/s10549-014-3229-7 Martins, 2009, Increased invasive behaviour in cutaneous squamous cell carcinoma with loss of basement-membrane type VII collagen, J. Cell Sci., 122, 1788, 10.1242/jcs.042895 Martins-Green, 2013, Chemokines and their receptors are key players in the orchestra that regulates wound healing, Adv. Wound Care, 2, 327, 10.1089/wound.2012.0380 Nakaya, 2007, Blockade of IP-10/CXCR3 promotes progressive renal fibrosis, Nephron Exp. Nephrol., 107, e12, 10.1159/000106505 O'Beirne, 2015, CXCL9 regulates TGF-β1-induced epithelial to mesenchymal transition in human alveolar epithelial cells, J. Immunol., 195, 2788, 10.4049/jimmunol.1402008 Romagnani, 2001, Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity, J. Clin. Investig., 107, 53, 10.1172/JCI9775 Romagnani, 2004, CXC chemokines: the regulatory link between inflammation and angiogenesis, Trends Immunol., 25, 201, 10.1016/j.it.2004.02.006 Rosenkilde, 2004, The chemokine system – a major regulator of angiogenesis in health and disease, APMIS, 112, 481, 10.1111/j.1600-0463.2004.apm11207-0808.x Sahin, 2013, Chemokines in tissue fibrosis, Biochem. Biophys. Acta, 1832, 1041 Shang, 2022, CXCL10 conditions alveolar macrophages within the premetastatic niche to promote metastasis, Cancer Lett., 537, 10.1016/j.canlet.2022.215667 Shao, 2008, Epidermal growth factor protects fibroblasts from apoptosis via PI3 kinase and rac signaling pathways, Wound Repair Regen., 16, 551, 10.1111/j.1524-475X.2008.00402.x Shiraha, 1999, IP-10 inhibits epidermal growth factor-induced motility by decreasing epidermal growth factor receptor-mediated calpain activity, J. Cell Biol., 146, 243, 10.1083/jcb.146.1.243 Swogger, 2021, Novel combination therapy reduces subconjunctival fibrosis after glaucoma filtration surgery in the rabbit model, Clin. Exp. Ophthalmol., 49, 60, 10.1111/ceo.13884 Tensen, 1999, Human IP-9: a keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3), J. Invest. Dermatol., 112, 716, 10.1046/j.1523-1747.1999.00581.x Wada, 2017, Serum-inducible protein (IP)-10 is a disease progression-related marker for non-alcoholic fatty liver disease, Hepatol. Int., 11, 115, 10.1007/s12072-016-9773-y Wasmuth, 2009, Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans, Gastroenterology, 137, 309, 10.1053/j.gastro.2009.03.053 Wells, 2016, Skin tissue repair: matrix microenvironment influences, Matrix Biol., 49, 25, 10.1016/j.matbio.2015.08.001 Weng, 1998, Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors, J. Biol. Chem., 273, 18288, 10.1074/jbc.273.29.18288 Wietecha, 2013, Mechanisms of vessel regression: toward an understanding of the resolution of angiogenesis, Curr. Top. Microbiol. Immunol., 367, 3 Worrell, 2020, CXCR3A promotes the secretion of the antifibrotic decoy receptor sIL-13Rα2 by pulmonary fibroblasts, Am. J. Physiol. Cell Physiol., 319, C1059, 10.1152/ajpcell.00076.2020 Wu, 2012, Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion, Mol. Cancer, 11, 3e, 10.1186/1476-4598-11-3 Xian, 2021, CXCR3 alleviates renal ischemia‑reperfusion injury via increase of Tregs, Mol. Med. Rep., 24, 10.3892/mmr.2021.12180 Yates, 2007, Delayed and deficient dermal maturation in mice lacking the CXCR3 ELR-negative CXC chemokine receptor, Am. J. Pathol., 171, 484, 10.2353/ajpath.2007.061092 Yates, 2008, ELR-negative CXC chemokine CXCL11(IP-9/I-TAC) facilitates dermal and epidermal maturation during wound repair, Am. J. Pathol., 173, 643, 10.2353/ajpath.2008.070990 Yates, 2009, Delayed re-epithelialization and basement membrane regeneration after wounding in mice lacking CXCR3, Wound Repair Regen., 17, 34, 10.1111/j.1524-475X.2008.00439.x Yates, 2010, Lack of CXC chemokine receptor 3 (CXCR3) signaling leads to hypertrophic and hypercellular scarring, Am. J. Pathol., 176, 1743, 10.2353/ajpath.2010.090564 Yates-Binder, 2012, An IP-10 (CXCL10)-derived peptide inhibits angiogenesis, PLoS One, 10.1371/journal.pone.0040812 Zhang, 2018, Reversing CXCL10 deficiency ameliorates kidney disease in diabetic mice, Am. J. Pathol., 188, 2763, 10.1016/j.ajpath.2018.08.017 Zhou, 2010, CXCR3-dependent accumulation and activation of perivascular macrophages is necessary for homeostatic arterial remodeling to hemodynamic stresses, J. Exp. Med., 207, 1951, 10.1084/jem.20100098 Zipin-Roitman, 2007, CXCL10 promotes invasion-related properties in human colorectal carcinoma cells, Cancer Res., 67, 3396, 10.1158/0008-5472.CAN-06-3087